Severe lung reaction to docetaxel treatment
Author Information
Author(s): Wang G-S, Yang K-Y, Perng R-P
Primary Institution: Chest Department, Taipei Veterans General Hospital; School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC
Hypothesis
Can docetaxel treatment lead to life-threatening hypersensitivity pneumonitis in patients with advanced non-small-cell lung cancer?
Conclusion
Docetaxel can cause life-threatening hypersensitivity pneumonitis that is difficult to treat.
Supporting Evidence
- Four patients developed life-threatening pneumonitis after docetaxel treatment.
- Pneumonitis was diagnosed based on clinical and radiological findings.
- Patients were treated with high doses of corticosteroids but showed persistent symptoms.
Takeaway
Some patients treated with docetaxel for lung cancer can develop a serious lung problem that makes it hard to breathe.
Methodology
Four patients with advanced non-small-cell lung cancer were treated with docetaxel and monitored for adverse reactions.
Limitations
The study is based on a very small sample size of only four patients.
Participant Demographics
Patients had advanced non-small-cell lung cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website